NSE BSE
pharmaids pharmaceuticals ltd. stock

PHARMAIDS PHARMACEUTICALS LTD. Share Price

- - (%)
Sector: -

524572

PHARMAID

img img img img
No Data Available

PHARMAIDS PHARMACEUTICALS LTD. Share Price Update


As of the latest trading session, PHARMAIDS PHARMACEUTICALS LTD. share price is currently at 58.49, which is up by 1.14 from its previous closing. Today, the stock has fluctuated between 58.49 and 58.49. Over the past year, PHARMAIDS PHARMACEUTICALS LTD. has achieved a return of 81.94 %. In the last month alone, the return has been -13.23 %.

PHARMAIDS PHARMACEUTICALS LTD. Performance

Day Range

Low58.49 High58.49
55.14

52 Week Range

Low 27.77 High 79.23
55.14

Open Price

58.49

Prev. Close

57.35

Volume (Shares)

6153.00

Total traded value

3.39

Upper Circuit

56.24

Lower Circuit

54.04

Note: The current prices & values are delayed, Login to your account for live updates.

PHARMAIDS PHARMACEUTICALS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 125.67
PE Ratio (TTM) 0.00
Book Value / Share 21.15
Beta 0.21
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -1.63

PHARMAIDS PHARMACEUTICALS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 0.02
Operating Expense 1.33
Net Profit -1.63
Net Profit Margin (%) -8150.00
Earnings Per Share (EPS) -0.76
EBITDA -2.20
Effective Tax Rate (%) 26.24
Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 1.03
Net Profit -0.50
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.23
EBITDA -1.28
Effective Tax Rate (%) 60.46
Particulars JUN 2023 (Values in Cr)
Revenue 0.00
Operating Expense 1.62
Net Profit -1.30
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.61
EBITDA -1.20
Effective Tax Rate (%) -7.43
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 8.60
Net Profit -6.16
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -4.79
EBITDA -8.60
Effective Tax Rate (%) 28.37
Particulars DEC 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.70
Net Profit -0.71
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.54
EBITDA -0.69
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 9.90
Net Profit -7.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -5.86
EBITDA -9.89
Effective Tax Rate (%) 23.71
Particulars MAR 2022 (Values in Cr)
Revenue 3.94
Operating Expense 3.81
Net Profit 0.15
Net Profit Margin (%) 3.80
Earnings Per Share (EPS) 0.14
EBITDA 0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 8.55
Operating Expense 8.49
Net Profit 0.09
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.09
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.37
Net Profit 0.03
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.03
EBITDA -0.34
Effective Tax Rate (%) 107.89
Particulars MAR 2019 (Values in Cr)
Revenue 0.56
Operating Expense 0.71
Net Profit -0.18
Net Profit Margin (%) -32.14
Earnings Per Share (EPS) -0.17
EBITDA -0.09
Effective Tax Rate (%) -21.42
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.31
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.30
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.30
ROE % 0.82
ROCE % 0.82
Total Debt to Total Equity 0.00
EBITDA Margin 1.52
Particulars MAR 2020 (Values in Cr)
Book Value / Share 8.21
ROE % 0.31
ROCE % -3.92
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2019 (Values in Cr)
Book Value / Share 8.18
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -17.86
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.58
Total Liabilities 24.58
Total Equity 22.46
Share Outstanding 21486234
Price to Book Ratio 2.12
Return on Assets (%) -30.72
Return on Capital (%) -33.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 21486234
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.55
Total Liabilities 24.55
Total Equity 22.42
Share Outstanding 21486234
Price to Book Ratio 2.12
Return on Assets (%) -30.77
Return on Capital (%) -33.69
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 10268819
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 9.11
Total Liabilities 9.11
Total Equity 8.52
Share Outstanding 10268819
Price to Book Ratio 1.35
Return on Assets (%) 1.02
Return on Capital (%) 1.09
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 8.45
Total Liabilities 8.45
Total Equity 8.43
Share Outstanding 10268819
Price to Book Ratio 0.55
Return on Assets (%) 0.39
Return on Capital (%) 0.4
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 8.66
Total Liabilities 8.66
Total Equity 8.39
Share Outstanding 10268819
Price to Book Ratio 0.58
Return on Assets (%) -2.04
Return on Capital (%) -2.11
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.30
Net change in Cash 12.34
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.30
Net change in Cash 12.34
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2021 (Values in Cr)
Net Income 0.08
Cash from Operations 0.40
Cash from Investing -0.22
Cash from Financing 0.00
Net change in Cash 0.17
Free Cash Flow 0.40
Particulars MAR 2020 (Values in Cr)
Net Income -0.37
Cash from Operations -0.75
Cash from Investing 0.66
Cash from Financing 0.00
Net change in Cash -0.08
Free Cash Flow -0.70
Particulars MAR 2019 (Values in Cr)
Net Income -0.14
Cash from Operations -0.10
Cash from Investing 0.00
Cash from Financing -0.02
Net change in Cash -0.12
Free Cash Flow -0.08
Company Name Price P/E P/B Market Cap 52 Week Low/High
PHARMAIDS PHARMACEUTICALS LTD. 57.35 0.00 2.71 202.26 28.50 / 79.23
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
PHARMAIDS PHARMACEUTICALS LTD. 57.35 0.00 2.71 202.26 28.50 / 79.23
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 55.50
  • 26 Days 55.90
  • 10 Days 55.20
  • 50 Days 56.90
  • 12 Days 55.20
  • 100 Days 54.40
  • 20 Days 57.20
  • 200 Days 43.80
57.35
PIVOT
First Resistance 57.35
Second Resistance 57.35
Third Resistance 57.35
First Support 57.35
Second Support 57.35
Third Support 57.35
RSI 44.12
MACD -0.72
Commodity Channel Index (CCI) 6.84
ADX 20.56
Williams % R -7.87

Over 1 Month

down

-13.23

Over 3 Months

down

10.94

Over 6 Months

down

40.08

Over 1 Year

down

81.94

Over 3 Years

down

24.31

Over 5 Years

down

62.89

PHARMAIDS PHARMACEUTICALS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

PHARMAIDS PHARMACEUTICALS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
94.36
Promoter Holdings
5.63
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Shreedhara Shetty Public Shareholding 6594446.0 18.7
Shankarappa Nagaraja Vinaya Babu Public Shareholding 5200000.0 14.74
Gokaram Ramakrishna Balaji Public Shareholding 3195815.0 9.06
Asian Hotels Public Shareholding 2722258.0 7.72
Tumkur Trade Center Private Limited Public Shareholding 1568000.0 4.45
Sadhanala Venkata Rao Shareholding of Promoter and Promoter Group 1550526.0 4.4
Narasandra Basavarajappa Pradeepkumar Public Shareholding 1125000.0 3.19
Venu Madhava Kaparthy Public Shareholding 876300.0 2.48
Sukhil S Mirji Public Shareholding 795854.0 2.26
Makam Sreevalli Public Shareholding 780242.0 2.21
Balagangadhara B C Public Shareholding 650000.0 1.84
Mini Manikantan Public Shareholding 500000.0 1.42
V Mahendra Public Shareholding 438097.0 1.24
S Prasad Public Shareholding 425201.0 1.21
Govindaraja Setty Srinivasa Mithra Public Shareholding 377910.0 1.07
Padmaja Kalyani Sadhanala Shareholding of Promoter and Promoter Group 189146.0 0.54
Pilli Meena Kumari Shareholding of Promoter and Promoter Group 56000.0 0.16
Viswa Prasad Sadhanala Shareholding of Promoter and Promoter Group 45045.0 0.13
Abhilekha Jain Shareholding of Promoter and Promoter Group 34128.0 0.1
Ghisulal Jain Shareholding of Promoter and Promoter Group 36070.0 0.1
Subhash B Lalwani Shareholding of Promoter and Promoter Group 32800.0 0.09
Veena Lalwani Shareholding of Promoter and Promoter Group 15645.0 0.04
Prashant H. Dave Shareholding of Promoter and Promoter Group 10459.0 0.03
Kant Rao Shareholding of Promoter and Promoter Group 7300.0 0.02
B Venkatswamy Shareholding of Promoter and Promoter Group 5000.0 0.01
Sureshkumar Shareholding of Promoter and Promoter Group 0.0 0.0
Abhishek Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Babulal Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Baghi Rao Pankaj Sadhanala Shareholding of Promoter and Promoter Group 25.0 0.0
Maharani Maheshwari Sadhanala Shareholding of Promoter and Promoter Group 25.0 0.0
Dadi Urmila Shareholding of Promoter and Promoter Group 25.0 0.0
Sadhanalla Dara Kalyani Shareholding of Promoter and Promoter Group 1000.0 0.0
Rangoori Kantham Shareholding of Promoter and Promoter Group 1000.0 0.0
B. Venkatswamy Shareholding of Promoter and Promoter Group 1070.0 0.0
Surekha Prashant Dave Shareholding of Promoter and Promoter Group 700.0 0.0
Uttam P Jain Shareholding of Promoter and Promoter Group 1000.0 0.0
Umadevi Babulal Jain Shareholding of Promoter and Promoter Group 1500.0 0.0

PHARMAIDS PHARMACEUTICALS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About PHARMAIDS PHARMACEUTICALS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by PHARMAIDS PHARMACEUTICALS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Pharmaids Pharmaceuticals Ltd?

Answer Field

The share price of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 58.49.

What is the Market Cap of Pharmaids Pharmaceuticals Ltd?

Answer Field

The market cap of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 125.67 Cr. as of now.

What is the 52 Week High and Low of Pharmaids Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 79.23 and ₹ 28.50.

How to Buy Pharmaids Pharmaceuticals Ltd share?

Answer Field

You can trade in Pharmaids Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Pharmaids Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 81.94%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader